Skip to main content
Clinical Trials/JPRN-jRCTs031220365
JPRN-jRCTs031220365
Recruiting
未知

An exploratory study to examine the usefulness of the AMPA receptor / GABA receptor expression density ratio in the brain measured from PET images in the prognosis evaluation of stroke hemiplegic patients.

Abe Hiroki0 sites35 target enrollmentOctober 6, 2022
Conditionsstroke

Overview

Phase
未知
Intervention
Not specified
Conditions
stroke
Sponsor
Abe Hiroki
Enrollment
35
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 6, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Abe Hiroki

Eligibility Criteria

Inclusion Criteria

  • Stroke Patients
  • 1\. 40 years older and 75 years younger at the registration
  • 2\. Diagnosed as initial symptomatic stroke within 60 days after onset
  • 3\. Those who have hemiplegia as a sequela of cerebral infarction or cerebral hemorrhage
  • 4\. Those who can start comprehensive rehabilitation for hemiplegia 30 to 90 days after the onset
  • 5\. Persons who have obtained documentary consent regarding participation in this research by their own free will.
  • However, if the consent explanation document cannot be read or written by the subject due to aphasia or paralysis, the witness will witness the entireprocess of informed consent, and the subject will voluntarily study this study at the time of obtainingconsent. Written in writing that you have decided to participate in. Witnesses are adults who are not unduly affected by those involved in this study and who can take a third\-party position. If it is determined that aphasia is incapable of giving informed consent, written consent with the signature of the substitute person requested by the person himself / herself is also possible. A surrogate is an adult who is equivalent to a spouse, parent, sibling, child, family member living together, or a close relative, and who can represent the will and interests of the person.
  • Healthy volunteers
  • 1\. 40 years older and 75 years younger at the registration
  • 2\. Persons who have obtained documentary consent regarding participation in this research by their own free will.

Exclusion Criteria

  • Stroke Patients
  • (1\) Those who have moderate or higher cognitive dysfunction \[Raven color matrix test (RCPM) 18 points or less or Mini\-mental state test (MMSE) 20 points or less]
  • (2\) Persons with epileptic seizures after cerebral infarction or cerebral hemorrhage
  • (3\) Those who require oral administration of perampanel during this study period
  • (4\) Those who require oral administration of clonazepam or clobazam during this study period
  • (5\) Those who cannot perform 3T\-head MRI examination
  • (6\) Those who are undergoing dialysis
  • (7\) Persons with hemiplegia, aphasia, or higherbrain dysfunction due to causes other than cerebral infarction or cerebral hemorrhage
  • (8\) Females suspected of becoming pregnant
  • (9\) In addition, those who are judged to be inappropriate for participation in this study at the discretion of the investigator, etc., such as the inability to implement appropriate contraceptive methods during the study period.

Outcomes

Primary Outcomes

Not specified

Similar Trials